why choose us

First received: February 19, 2023

Clinical Trial: Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Urothelial Carcinoma

Study Type: INTERVENTIONAL


Official Title: Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma After Prior Chemotherapy: a Open-label, Multicenter Phase II Study (UTRUST)

Brief Summary: This study is a open-label, multicenter, phase II study to evaluate the efficacy and safety of utidelone in the recurrent or metastatic urothelial carcinoma after prior chemotherapy.

Read more